Education
About Us
Working with TipRanks
Follow Us
Celon Pharma SA (DE:8RP)
:8RP
8RP Stock Chart & Stats
Day’s Range― - ―
52-Week Range€4.81 - €7.14
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€286.90M
Enterprise Value€1.37B
Total Cash (Recent Filing)€52.52M
Total Debt (Recent Filing)€19.79M
Price to Earnings (P/E)69.6
Beta0.48
Next Earnings
Sep 17, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding53,856,500
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Celon Pharma SA News
8RP FAQ
What was Celon Pharma SA’s price range in the past 12 months?
Celon Pharma SA lowest stock price was €4.81 and its highest was €7.14 in the past 12 months.
What is Celon Pharma SA’s market cap?
Celon Pharma SA’s market cap is €286.90M.
When is Celon Pharma SA’s upcoming earnings report date?
Celon Pharma SA’s upcoming earnings report date is Sep 17, 2025 which is in 32 days.
How were Celon Pharma SA’s earnings last quarter?
Currently, no data Available
Is Celon Pharma SA overvalued?
According to Wall Street analysts Celon Pharma SA’s price is currently Overvalued.
Does Celon Pharma SA pay dividends?
Celon Pharma SA does not currently pay dividends.
What is Celon Pharma SA’s EPS estimate?
Celon Pharma SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Celon Pharma SA have?
Celon Pharma SA has 53,856,500 shares outstanding.
What happened to Celon Pharma SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Celon Pharma SA?
Currently, no hedge funds are holding shares in DE:8RP
Company Description
Celon Pharma SA
Celon Pharma S.A., an integrated pharmaceutical company, researches, manufactures, and markets pharmaceutical products and preparations. The company operates through Generic Drug and Innovative segments. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. is a subsidiary of Glatton Sp. z o.o.
Technical Analysis
Ownership Overview
―
Insiders
0.19%
Mutual Funds
― Other Institutional Investors
99.81% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---